2022 Regular SessionMaryland Legislature

HB970: Managed Care Organizations and Health Insurance Carriers - Prior Authorization for HIV Postexposure Prophylaxis - Prohibition

Legislative Summary

Prohibiting managed care organizations and certain insurers, nonprofit health service plans, and health maintenance organizations from applying a prior authorization requirement for prescription drugs used as postexposure prophylaxis for the prevention of HIV if the drug is prescribed for use in accordance with Centers for Disease Control and Prevention guidelines.

Demographic Impact

Overall analysis of equity impact

90% Positive
High ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

2/10/2022
First Reading Health and Government Operations
House of Delegates
2/11/2022
Hearing 2/17 at 1:30 p.m.
House of Delegates
2/28/2022
Favorable with Amendments Report by Health and Government Operations
House of Delegates
3/1/2022
Favorable with Amendments {593625/1 Adopted
House of Delegates
3/1/2022
Second Reading Passed with Amendments
House of Delegates
3/3/2022
Third Reading Passed (133-0)
House of Delegates
3/4/2022
Referred Finance
Senate
4/7/2022
Favorable Report by Finance
Senate
4/7/2022
Favorable Adopted
Senate
4/7/2022
Second Reading Passed
Senate
4/8/2022
Third Reading Passed (47-0)
Senate
4/9/2022
Returned Passed
House of Delegates
5/29/2022
Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 684
House of Delegates

Amendments

Favorable with Amendments 593625/1 Adopted

Favorable with Amendments 593625/1 Adopted

3/1/2022Adopted

Roll Call Votes

Third Reading Passed
4/8/2022
47
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
Third Reading Passed
3/3/2022
133
Yea
0
Nay
0
Not Voting
8
Absent
Result: PASSED